ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 117 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $980,650 | -41.1% | 27,500 | -33.0% | 0.66% | -35.2% |
Q4 2022 | $1,664,136 | -42.5% | 41,029 | -53.1% | 1.02% | -17.8% |
Q3 2022 | $2,892,000 | +32.7% | 87,500 | +41.3% | 1.24% | +2.6% |
Q2 2022 | $2,180,000 | -42.5% | 61,926 | -24.9% | 1.21% | -31.5% |
Q1 2022 | $3,794,000 | -45.8% | 82,500 | -21.8% | 1.77% | -39.7% |
Q4 2021 | $6,995,000 | -7.8% | 105,500 | -13.2% | 2.94% | +9.9% |
Q3 2021 | $7,585,000 | -15.2% | 121,500 | +12.5% | 2.68% | -25.1% |
Q2 2021 | $8,945,000 | +24.9% | 108,000 | 0.0% | 3.58% | +38.5% |
Q1 2021 | $7,161,000 | -32.9% | 108,000 | -22.3% | 2.58% | -11.0% |
Q4 2020 | $10,665,000 | +144.0% | 139,000 | +36.9% | 2.90% | +144.5% |
Q3 2020 | $4,371,000 | +68.7% | 101,500 | +69.2% | 1.19% | +58.5% |
Q2 2020 | $2,591,000 | -17.9% | 60,000 | -45.3% | 0.75% | -51.0% |
Q1 2020 | $3,156,000 | -88.8% | 109,700 | -75.2% | 1.53% | -78.0% |
Q4 2019 | $28,068,000 | +157.0% | 442,500 | +14.2% | 6.95% | -11.8% |
Q3 2019 | $10,920,000 | -13.9% | 387,500 | -19.0% | 7.88% | +74.8% |
Q2 2019 | $12,680,000 | +312.5% | 478,500 | +185.7% | 4.51% | +208.4% |
Q1 2019 | $3,074,000 | -83.6% | 167,500 | -82.8% | 1.46% | -78.1% |
Q3 2018 | $18,691,000 | +11.7% | 975,000 | -20.8% | 6.67% | +123.9% |
Q2 2018 | $16,732,000 | +31.7% | 1,230,330 | -30.2% | 2.98% | +43.5% |
Q1 2018 | $12,706,000 | – | 1,762,206 | – | 2.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |